What are the clinical features and detection methods for congenital hypothyroidism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Clinical Features and Detection of Congenital Hypothyroidism

Clinical Features

Most newborns with congenital hypothyroidism appear clinically normal at birth, making biochemical screening essential rather than relying on clinical diagnosis alone 1, 2. The clinical signs are typically subtle and nonspecific in the neonatal period.

Key Clinical Manifestations

When present, the following features are most discriminatory:

  • Feeding difficulties - poor feeding, not waking for feeds, slow feeding
  • Constipation
  • Dry skin
  • Umbilical hernia
  • Enlarged posterior fontanelle (persistence beyond expected closure)
  • Prolonged neonatal jaundice (>2 weeks)
  • Lethargy and hypotonia
  • Macroglossia
  • Cold extremities
  • Coarse/puffy facial features

1, 3, 4, 2

Important Clinical Caveat

Even using structured clinical scoring systems (like the Quebec neonatal hypothyroid index), only 50% of hypothyroid infants score above the threshold of 2 points 2. This underscores why clinical examination alone is inadequate for diagnosis and why universal biochemical screening is mandatory 1, 3.

Severity Assessment

CH severity should be assessed using multiple parameters simultaneously 1:

Biochemical severity (based on serum FT4 at diagnosis):

  • Severe: FT4 <5 pmol/L
  • Moderate: FT4 5-10 pmol/L
  • Mild: FT4 10-15 pmol/L

Skeletal maturation markers:

  • Absent distal femoral and/or proximal tibial epiphyses on knee X-ray indicates severe intrauterine hypothyroidism and correlates with worse neurodevelopmental outcomes 1

Associated findings requiring examination 1:

  • All neonates with elevated TSH must be carefully examined for congenital malformations, particularly cardiac defects, and dysmorphic features - these associations are common enough to warrant systematic evaluation

Detection Methods

Newborn Screening Strategy

Universal neonatal screening using dried blood spot (DBS) testing is the cornerstone of CH detection, optimally performed between 2-5 days of age 1, 3.

Screening Approaches

Different programs use:

  • Primary TSH measurement (most common in Europe)
  • Primary T4 with backup TSH (common in North America)
  • Combined TSH and T4

1, 3

High-Risk Populations Requiring Second Screen

A second screening test should be performed for 1:

  • Preterm infants
  • Low birth weight (<2500g) and very low birth weight infants
  • Ill neonates in NICU
  • Specimens collected within first 24 hours of life
  • Multiple births, especially same-sex twins

Diagnostic Algorithm After Abnormal Screen

Immediate Action Thresholds

If capillary TSH ≥40 mU/L whole blood: Start treatment immediately after obtaining venous sample, without waiting for confirmatory results 1

If capillary TSH <40 mU/L whole blood: May wait for venous results, but these must be available within 24 hours 1

Confirmatory Venous Testing

Obtain serum TSH and free T4 (or total T4) using age-specific reference ranges - thyroid function undergoes dynamic changes in the first weeks of life 1, 3.

Treatment Initiation Criteria (Venous Results)

Start treatment immediately if:

  • Venous FT4 is below age-specific norms (regardless of TSH level) 1
  • Venous TSH ≥20 mU/L (even if FT4 is normal) 1

For TSH 6-20 mU/L beyond 21 days of age with normal FT4:

  • Perform diagnostic imaging (thyroid ultrasound and/or scintigraphy)
  • Discuss with family: either start treatment immediately with plan to retest off treatment later, OR retest in 2 weeks without treatment
  • If TSH remains elevated >3-4 weeks, initiate treatment 1

Diagnostic Imaging

Thyroid imaging should be performed using radioisotope scanning (scintigraphy) with or without perchlorate discharge test, and/or ultrasonography 1.

Critical principle: Imaging must never delay treatment initiation 1.

Imaging Purposes

  • Determine etiology (thyroid dysgenesis vs. dyshormonogenesis)
  • Assess gland location (ectopic vs. eutopic)
  • Identify athyreosis, hypoplasia, or goiter
  • Guide prognosis and genetic counseling

Serum thyroglobulin below detection threshold strongly suggests athyreosis or complete thyroglobulin synthesis defect 1.


Communication Protocol

Abnormal screening results must be communicated by experienced personnel (screening laboratory staff or pediatric endocrine team) via telephone or in person 1.

The infant should be seen for clinical assessment and venous testing on the day of referral or next day at latest 1.

Parents should be shown how to administer the first levothyroxine dose by the clinician or pharmacist 1.

Important: When the child reaches school age, educators and teachers should NOT be informed about the CH diagnosis to avoid stigmatization and labeling 1.


Special Considerations

Delayed TSH Rise

Some infants display delayed TSH elevation despite normal initial screening - this pattern may be more common and severe than previously recognized, particularly in preterm and NICU infants 5. This justifies the second screening recommendation for high-risk populations.

Central (Secondary) Hypothyroidism

While much less common than primary CH, central hypothyroidism can be equally severe. TSH-based screening will miss these cases; T4-based or combined screening strategies are needed for detection 5.

References

Research

Clinical characteristics of congenital hypothyroidism detected by neonatal screening.

Journal of the Formosan Medical Association = Taiwan yi zhi, 1993

Research

Congenital hypothyroidism.

Indian journal of endocrinology and metabolism, 2015

Research

Hypothyroidism and hyperthyroidism.

Acta bio-medica : Atenei Parmensis, 2019

Research

Update on congenital hypothyroidism.

Current opinion in endocrinology, diabetes, and obesity, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.